Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barter

Showing results (351-360 of 390) with videos related to

Pageof 39
Sort By:
Diabetologia|November 27, 2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Nature Reviews. Cardiology|August 11, 2017
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biologyRobert S Rosenson, H Bryan Brewer, Philip J Barter, et al.
Arthritis and Rheumatism|April 12, 2013
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradationKirsty L Culley, Wang Hui, Matt J Barter, et al.
American Heart Journal|January 14, 2020
Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trialTaufiq Salahuddin, John Kittelson, Jean-Claude Tardif, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAAJ Smith, J-A Nazare, A-L Borel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2010
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-IEstelle Nobécourt, Fatiha Tabet, Gilles Lambert, et al.
Arthritis and Rheumatism|December 7, 2011
The expression and function of microRNAs in chondrogenesis and osteoarthritisTracey E Swingler, Guy Wheeler, Virginia Carmont, et al.
The New England Journal of Medicine|March 28, 2007
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemiaJohn J P Kastelein, Sander I van Leuven, Leslie Burgess, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Nature Communications|March 1, 2014
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cellsFatiha Tabet, Kasey C Vickers, Luisa F Cuesta Torres, et al.
Pageof 39

Showing results (351-360 of 390) with videos related to

Sort By:
Pageof 39
Diabetologia|November 27, 2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Nature Reviews. Cardiology|August 11, 2017
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biologyRobert S Rosenson, H Bryan Brewer, Philip J Barter, et al.
Arthritis and Rheumatism|April 12, 2013
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradationKirsty L Culley, Wang Hui, Matt J Barter, et al.
American Heart Journal|January 14, 2020
Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trialTaufiq Salahuddin, John Kittelson, Jean-Claude Tardif, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAAJ Smith, J-A Nazare, A-L Borel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2010
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-IEstelle Nobécourt, Fatiha Tabet, Gilles Lambert, et al.
Arthritis and Rheumatism|December 7, 2011
The expression and function of microRNAs in chondrogenesis and osteoarthritisTracey E Swingler, Guy Wheeler, Virginia Carmont, et al.
The New England Journal of Medicine|March 28, 2007
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemiaJohn J P Kastelein, Sander I van Leuven, Leslie Burgess, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Nature Communications|March 1, 2014
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cellsFatiha Tabet, Kasey C Vickers, Luisa F Cuesta Torres, et al.
Pageof 39